Enzychem Lifesciences Company Description

Enzychem Lifesciences Corporation engages in developing novel small molecule therapeutics for patients with unmet needs for oncology, inflammatory, and severe respiratory diseases in South Korea.

It is also developing EC-18, an oral small molecule for fibrotic diseases, such as nonalcoholic steatohepatitis; and in severe respiratory diseases as a potential therapy for COVID-19.

The company was founded in 1999 and is headquartered in Seoul, South Korea.

Enzychem Lifesciences Corporation

Country	South Korea
Founded	1999
Industry	Pharmaceutical Preparations
Employees	122
CEO	Ki-Young Sohn

Contact Details

Address: aT Center Seoul South Korea
Phone	82 2 501 1084
Website	enzychem.com

Stock Details

Ticker Symbol	183490
Exchange	KOSDAQ
Fiscal Year	January - December
Reporting Currency	KRW
SIC Code	2834

Key Executives

Name	Position
Ki-Young Sohn	Chief Executive Officer